Abiomed, Inc.

Getinge's subsidiary Maquet Cardiovascular receives adverse jury trial verdict in patent infringement dispute with Abiomed in the U.S.

IoMT Wearable Devices Patent Landscape Report and Forecasts, 2017-2023 & 2024-2032 Featuring Veniam, Advanced Neuromodulation Systems, Bionet Sonar, and Abiomed

US FDA classifies recall of Abiomed's blood pumps as most serious

3 Reasons to Retain Abiomed (ABMD) Stock in Your Portfolio

FDA Approves Impella ECP Pivotal Heart Pump and First Patients Enrolled in Pivotal Clinical Trial

Warren Buffett Loves These Stocks. Should You Buy Them Before 2023?

Johnson & Johnson Announces Extension of Abiomed Tender Offer to December 21, 2022

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ELVT, OPNT, BNFT, ABMD

First Patients in the World Treated with Impella RP Flex with SmartAssist

Eleven Stocks Turned $10,000 To $261,421 In 11 Months

Johnson & Johnson Could Level Up With Its $16.8 Billion Purchase of Abiomed

Is Johnson & Johnson's Purchase of Abiomed Good for Investors?

Beat the Dow Jones With This Unstoppable Dividend Stock

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating ABIOMED, Inc. Buyout

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATCO, ABMD, BNFT

ABIOMED INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Abiomed, Inc. - ABMD

SHAREHOLDER ALERT: Weiss Law Investigates Abiomed, Inc.

Why Abiomed Stock Skyrocketed Today

Abiomed Shares Pop 50% on Johnson & Johnson Buyout

Abiomed, Inc. (ABMD) Q2 2023 Earnings Call Transcript